Skip to main content
. Author manuscript; available in PMC: 2009 Sep 23.
Published in final edited form as: Biochim Biophys Acta. 2008 Jun 17;1781(9):448–458. doi: 10.1016/j.bbalip.2008.05.005

Figure 3.

Figure 3

SPL inhibitors. Several sphingolipid analogs inhibit enzyme activity and lately compounds such as the ceramide analog GT11, the LCB analog FTY720 and the LCBP analog FTY720-phosphate has been shown to inhibit SPL. Moreover, pyridoxal-phosphate analogs including THI, has also been shown to inhibit SPL.